Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
multiple sclerosis
Biotech
Contineum shifts cash from MS to lung disease showdown with BMS
Contineum has pumped the brakes on two projects, freeing up resources to go full speed ahead in its pursuit of BMS in idiopathic pulmonary fibrosis.
Nick Paul Taylor
Aug 6, 2025 9:51am
Roche links BTK drug to low relapse rate across 96-week MS trial
May 30, 2025 5:19am
Immunic MS asset misses primary goal of midstage trial
Apr 30, 2025 3:05pm
Acelyrin to be absorbed into Alumis in all-stock merger
Feb 7, 2025 5:35am
Investigational MS drug restores mobility in mice
Jan 2, 2025 2:15pm
Sanofi will deploy new AI tool in late-stage MS trials
Nov 13, 2024 7:40am